Pharmena S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was PLN 0.299 million compared to PLN 0.299 million a year ago. Net income was PLN 28.94 million compared to net loss of PLN 1.57 million a year ago.

Basic earnings per share from continuing operations was PLN 2.43 compared to basic loss per share from continuing operations of PLN 0.46 a year ago. Diluted earnings per share from continuing operations was PLN 2.43 compared to diluted loss per share from continuing operations of PLN 0.46 a year ago. Basic earnings per share was PLN 2.6 compared to basic loss per share of PLN 0.14 a year ago.

Diluted earnings per share was PLN 2.6 compared to diluted loss per share of PLN 0.14 a year ago.